A rare eye disease has been added to the growing list of side effects linked to GLP-1s, adding a second eye warning to several labels. Michael Siluk/UCG/Universal Images Group via Getty Images The FDA is requiring new warnings on Ozempic, Wegovy, Mounjaro, Zepbound, and other GLP-1s about a potential increase in the risk of a rare eye condition that can cause sudden vision loss. Regulators in the…
Nigeria’s Health Minister, Muhammad Pate, reports a 60% drop in maternal deaths in areas under the FG’s MAMII initiative, citing improved healthcare access Read More…
An international panel of scientific experts will convene on Tuesday to evaluate the status, but genetic data already shows the virus is once again endemic in the United States.
(MedPage Today) -- Results from the phase III PREVAIL trial presented at the American Association of Neuromuscular & Electrodiagnostic Medicine annual meeting showed that treatment with the…
These six travel vaccines for Africa, Asia and South America cover entry rules, food and water risks, and measles and polio exposure, plus when to book a clinic visit
The deal is designed to marry UNP’s macrocyclic peptide discovery platform with Argenx’s immunology innovation capabilities to broaden the buyer’s ability to develop oral or long-acting treatments for…
